Obbligazioni in dollari Keep Calm And Invest Preferred Shares Usa

[pv78]

Beh io oggi ho alleggerito parecchio, tutte le mattine ci svegliamo con delle bad news dalla Corea

A comprare si fa sempre in tempo, a vendere delle volte si fa fatica

In attesa di guardare meglio Ras,sottolineo che per ciò che riguarda le preferred per me la preoccupazione maggiore è il dollaro.....

Cordiali saluti

 

[tommy03]

Vendute le Ashford di cui sopra a 25,66 e incrementate MTBC a 25,15

puoi mettere l'isin di quelle acquistate ??

 

[Fabrib]

puoi mettere l'isin di quelle acquistate ??

Medical Trans Bill 11% Pref Perp$ 25,250,24(0,96%)05/09/2017
Codice US19772 ISIN US58464J2042
Mercato NASDAQ

 

[Peco]

Adcare Health Systems Inc Fusione 10.875 % Cum Red Pfd Registered Shs Adcare Health Systems Inc Series -AValore 20036684 200 ISIN US00650W4096 La società in oggetto ha annunciato la fusione con la Regional Health Properties Inc che deve ancora essere approvata dall'assemblea generale straordinaria del 20.9.2017. Se la fusione sarà approvata, le azioni Adcare Health Systems Inc saranno scambiate. Rapporto di scambio: 1 nuova azione privilegiata Regional Health Properties Inc per 1 azione privilegiata Adcare Health Systems Inc posseduta Giorno di riferimento 15.10.2017 previsto: Il reddito derivante dalla presente transazione può essere considerato negli Stati Uniti come reddito da dividendo imponibile e sarà quindi presumibilmente soggetto all'imposta alla fonte americana. A Imposta alla fonte: seconda della convenzione sulla doppia imposizione, la ritenuta alla fonte può ammontare fino al 30%. Prezzo di borsa USD 21.66 in data 1.9.2017 a New York dell'azione privilegiata Adcare Health Systems Inc posseduta: Se la fusione sarà approvata, scambieremo i titoli a tempo debito e vi invieremo un rispettivo conteggio.
ricevuto avviso questa mattina . se a qualcuno interessa

Grazie captain

AdCare Health Systems sta proponendo ai suoi azionisti un piano di fusione con Regional Health Properties, Inc., una sua filiale interamente controllata. Lo scopo principale di questa fusione è rendere AdCare conforme alla sezione 1003 del NYSE MKT che richiede per la quotazione un patrimonio netto di almeno $2 milioni a una società che ha riportato perdite nette in due dei suoi ultimi tre bilanci. Con la fusione AdCare cambierebbe il nome ma soprattutto potrebbe includere le sue azioni privilegiate ADK-A nel proprio patrimonio consolidato anziché nel patrimonio temporaneo come sono classificate adesso.
Nel suo ultimo esercizio AdCare aveva segnalato un patrimonio negativo di $ 40,7 milioni mentre aveva $ 61,4 milioni di azioni privilegiate classificate come temporanee. Se le azioni privilegiate fossero state classificate in bilancio come permanenti il patrimonio netto sarebbe stato positivo di $20,7 milioni. La nuova società inoltre sembrerebbe voglia richiedere lo status di reit. Se il piano sarà approvato le pref ADK-A scambieranno con il simbolo RHP-A

 

[mac]

tieni presente che le preferred di banche Usa sono T2 gli irs di banche europee e inglesi sono T1 almeno fino al 2022

Non sto comprando IRS ma le arcinote C.A. 7,375% e BNP 6,5%

 

[fabriziof]

Non sto comprando IRS ma le arcinote C.A. 7,375% e BNP 6,5%

Sempre t1 sono

 

[Fabrib]

09/07/2017 | 08:32am EDT
RAIT Financial Trust (NYSE: RAS) (“RAIT”) today announced that the Board of Trustees of RAIT (the “Board”) has formed a committee of independent members (the “Special Committee”) to explore and evaluate strategic and financial alternatives to enhance shareholder value and capitalize on RAIT’s established and respected commercial real estate lending platform. Such alternatives may include, but are not limited to, (i) refinements of RAIT’s operations or strategy, (ii) financial transactions, such as a recapitalization or other change to RAIT’s capital structure and (iii) strategic transactions, such as a sale of all or part of RAIT.
Michael Malter, Chairman of the Board and a member of the Special Committee, said, “Our Board of Trustees and management team continue to focus on executing on the current strategic plan and remain committed to maximizing value for our shareholders. After careful consideration, the Board believes now is the appropriate time to explore a broad range of strategic and financial alternatives that may have the potential to further unlock and enhance shareholder value." The other members of the Special Committee are Justin P. Klein, who serves as Chairman of the Special Committee, and Thomas D. Wren.
The Special Committee has not set a definitive timetable for completion of its evaluation, and there can be no assurances that the process will result in any change in strategy or any transaction being announced or completed. RAIT does not intend to make any further public comment regarding the evaluation until the outcome of the process is determined.
RAIT and the Special Committee have retained Barclays and UBS Investment Bank as financial advisors and Winston & Strawn LLP as legal advisor to assist in the evaluation

 

[pv78]

09/07/2017 | 08:32am EDT
RAIT Financial Trust (NYSE: RAS) (“RAIT”) today announced that the Board of Trustees of RAIT (the “Board”) has formed a committee of independent members (the “Special Committee”) to explore and evaluate strategic and financial alternatives to enhance shareholder value and capitalize on RAIT’s established and respected commercial real estate lending platform. Such alternatives may include, but are not limited to, (i) refinements of RAIT’s operations or strategy, (ii) financial transactions, such as a recapitalization or other change to RAIT’s capital structure and (iii) strategic transactions, such as a sale of all or part of RAIT.
Michael Malter, Chairman of the Board and a member of the Special Committee, said, “Our Board of Trustees and management team continue to focus on executing on the current strategic plan and remain committed to maximizing value for our shareholders. After careful consideration, the Board believes now is the appropriate time to explore a broad range of strategic and financial alternatives that may have the potential to further unlock and enhance shareholder value." The other members of the Special Committee are Justin P. Klein, who serves as Chairman of the Special Committee, and Thomas D. Wren.
The Special Committee has not set a definitive timetable for completion of its evaluation, and there can be no assurances that the process will result in any change in strategy or any transaction being announced or completed. RAIT does not intend to make any further public comment regarding the evaluation until the outcome of the process is determined.
RAIT and the Special Committee have retained Barclays and UBS Investment Bank as financial advisors and Winston & Strawn LLP as legal advisor to assist in the evaluation

Ci mandiamo Peco....

 

[wallner]

09/07/2017 | 08:32am EDT
RAIT Financial Trust (NYSE: RAS) (“RAIT”) today announced that the Board of Trustees of RAIT (the “Board”) has formed a committee of independent members (the “Special Committee”) to explore and evaluate strategic and financial alternatives to enhance shareholder value and capitalize on RAIT’s established and respected commercial real estate lending platform. Such alternatives may include, but are not limited to, (i) refinements of RAIT’s operations or strategy, (ii) financial transactions, such as a recapitalization or other change to RAIT’s capital structure and (iii) strategic transactions, such as a sale of all or part of RAIT.
Michael Malter, Chairman of the Board and a member of the Special Committee, said, “Our Board of Trustees and management team continue to focus on executing on the current strategic plan and remain committed to maximizing value for our shareholders. After careful consideration, the Board believes now is the appropriate time to explore a broad range of strategic and financial alternatives that may have the potential to further unlock and enhance shareholder value." The other members of the Special Committee are Justin P. Klein, who serves as Chairman of the Special Committee, and Thomas D. Wren.
The Special Committee has not set a definitive timetable for completion of its evaluation, and there can be no assurances that the process will result in any change in strategy or any transaction being announced or completed. RAIT does not intend to make any further public comment regarding the evaluation until the outcome of the process is determined.
RAIT and the Special Committee have retained Barclays and UBS Investment Bank as financial advisors and Winston & Strawn LLP as legal advisor to assist in the evaluation

Se c'è fumo, ci deve essere anche un incendio...

 

[bia06]

Ciao, puoi postare qualche prezzo eseguito? Giusto per confrontarci in questo periodo di bassa liquidita´ OTC.

Non sto comprando IRS ma le arcinote C.A. 7,375% e BNP 6,5%